Doctors Want Stricter Rules on Dietary Supplements

Doctors Want Stricter Rules on Dietary Supplements

If you take a daily multivitamin, a protein powder, or a sleep aid from your local pharmacy, here's something that might surprise you: none of those products had to prove they were safe or effective before landing on the shelf. That's the regulatory reality in the United States right now, and a major medical organization just made clear it thinks that needs to change.

The American College of Physicians (ACP), one of the largest physician organizations in the world with over 160,000 members, recently published a formal position paper calling for sweeping reforms to how dietary supplements are regulated. The paper doesn't mince words. It describes the current system as a genuine public health risk, and it's asking the FDA to take on powers it simply doesn't have today.

The Core Problem: Supplements Don't Have to Prove Anything First

Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), supplements are treated more like food than medicine. Manufacturers don't need to demonstrate safety or efficacy before selling a product. The FDA can only act after something goes wrong, and even then, the burden of proof often falls on the agency, not the company.

This isn't a niche issue. The US supplement industry generates over $50 billion in annual revenue. Americans buy billions of individual supplement products every year, from fish oil capsules to pre-workout blends to herbal weight-loss formulas. The scale of consumption makes the regulatory gap significant.

The ACP's position paper argues that this framework was outdated the moment it passed, and that the explosion in supplement use over the past three decades has made reform urgent. The organization is now pushing for a model that looks much closer to how pharmaceuticals are handled.

What the ACP Is Demanding

The position paper outlines several specific proposals. They're worth understanding individually because each one closes a different loophole in the current system.

Mandatory premarket registration and approval. The ACP wants every new supplement to go through a formal approval process before it can be sold. That means manufacturers would need to submit safety data to the FDA and receive clearance. Right now, companies can launch products with almost no federal review. This single change would represent the biggest structural shift in supplement regulation in 30 years.

Improved postmarket surveillance. Even after a product is on shelves, there's currently no consistent system for tracking what happens to the people who use it. Adverse event reporting is largely voluntary. The ACP is calling for a more rigorous, mandatory system so that problems can be detected faster and patterns identified before widespread harm occurs.

Expanded FDA recall authority. Today, the FDA can request a voluntary recall of a dangerous supplement, but it lacks unilateral authority to force one. The ACP wants that to change, giving regulators the power to act quickly when a product poses a clear risk.

A national supplement database. This is one of the most practical proposals in the paper. A centralized, publicly accessible database would allow healthcare providers, researchers, and consumers to look up products, check ingredient lists, and review any reported adverse events. It would also make it possible to track patterns across the market in a way that's currently impossible.

If you've ever wondered whether the label on your supplement actually reflects what's inside the bottle, this database would begin to address that gap. Research has repeatedly shown that label accuracy in the supplement industry is inconsistent, a problem covered in detail in Can You Actually Trust What's on Your Supplement Label?

Why This Matters More Than It Sounds

It's easy to assume that supplements are low-stakes. They're sold at grocery stores, they're often plant-based, and many are things you'd recognize from your kitchen. But the risk profile is more complicated than that.

The FDA receives thousands of adverse event reports related to supplements each year, ranging from minor gastrointestinal issues to serious liver damage and cardiac events. Research published in medical journals has estimated that supplement-related adverse events account for tens of thousands of emergency department visits annually in the US. Many more cases go unreported because consumers don't connect their symptoms to a supplement they're taking.

Contamination is another layer of the problem. Third-party testing has found that some supplements contain undisclosed prescription drug ingredients, heavy metals, or substances banned in professional sports. This is especially common in weight-loss, sexual enhancement, and muscle-building categories. The issue is documented and ongoing. Why Supplement Labels Still Can't Be Trusted in 2026 breaks down how this problem has persisted despite years of industry pressure to self-regulate.

The ACP's position is that voluntary compliance and industry self-regulation haven't worked. The paper makes the case that meaningful consumer protection requires structural change at the regulatory level, not just better labeling guidelines.

What the Industry Says

Supplement manufacturers and trade groups have consistently opposed stricter regulation, arguing that a premarket approval process would create enormous compliance costs that push smaller companies out of the market. They also contend that most supplements are safe, that enforcement resources would be better spent on bad actors, and that consumer choice would be restricted under a pharmaceutical-style review process.

These arguments aren't without some merit. A full FDA approval pathway for every supplement would be expensive and time-consuming. The question is whether the current system, which allows products to reach millions of consumers without any independent safety review, is the right baseline to be defending.

The ACP's answer is clearly no. And with physician organizations, consumer advocates, and some legislators increasingly aligned on this issue, the political momentum behind reform is stronger than it's been in years.

What You Can Do Right Now While Regulation Catches Up

If you're currently taking supplements or considering adding them to your routine, the regulatory gap is a practical problem you need to navigate today. Here's how to approach it.

• Look for third-party certification. Organizations like NSF International, USP (US Pharmacopeia), and Informed Sport independently test supplements for label accuracy and contamination. A product carrying one of these seals has been verified by a party with no financial interest in the result. This doesn't guarantee efficacy, but it's the strongest quality signal available to consumers right now.
• Check the FDA's warning database. The FDA maintains a publicly searchable list of supplements that have received warnings or been subject to recalls. It's not comprehensive, but it's a useful first filter before you buy.
• Be skeptical of proprietary blends. When a label lists a "proprietary blend" without specifying individual ingredient doses, you have no way to evaluate whether the amounts are meaningful or safe. This is a common practice in sports supplements and weight-loss products.
• Talk to a healthcare provider before adding anything new. This is especially relevant if you're taking prescription medications, managing a chronic condition, or pregnant. Many supplement-drug interactions are clinically significant and poorly understood by consumers.
• Use personalized data when possible. Blood work and biomarker testing can tell you whether you're actually deficient in something before you supplement. Personalized Nutrition: How to Actually Use Your Blood Work walks through how to use that information practically.
• Start with diet first. For most micronutrients, whole food sources are better absorbed and come without the label accuracy concerns of bottled supplements. Simple Diet Changes That Actually Move the Needle outlines where dietary adjustments tend to produce the most meaningful results.

The Bigger Picture

The ACP's position paper is a formal statement from an organization that represents practicing physicians across internal medicine and its subspecialties. It's not a fringe view. It reflects what many doctors see in clinical practice: patients taking supplements they believe are safe and regulated, without understanding that the regulatory framework they're imagining doesn't actually exist.

Whether Congress acts on these recommendations is a separate question. Supplement regulation reform has stalled multiple times over the past decade, blocked by industry lobbying and competing legislative priorities. But the ACP's intervention raises the political and professional stakes.

In the meantime, you're operating in a market where what's on the label may not match what's in the bottle, where safety data is often absent, and where serious adverse events don't always get reported. That's not a reason to avoid supplements entirely, but it is a reason to be deliberate about which ones you take, why you're taking them, and how you're evaluating the quality of what you're buying.

The system is supposed to protect you. Right now, it largely doesn't. That's what the ACP is trying to change.